Details of the Drug Formulaction

General Information of Drug Formulation (ID: F13563)

• Formulation Name: Methylphenidate 20 mg capsule
• Company: Actavis Pharma; Actavis South Atlantic; American Health Packaging

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Methylphenidate	(DM7SJD6)	Attention deficit hyperactivity disorder	6A05.Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Acetone	(E00004)	180	Solvent
Acetyltributyl citrate	(E00127)	6505	Plasticizing agent
Ferrosoferric oxide	(E00231)	14789	Colorant
Potassium hydroxide	(E00233)	14797	Alkalizing agent
Saccharose	(E00091)	5988	Binding agent; Coating agent; Cryoprotectant; Diluent; Flavoring agent; Suspending agent; Viscosity-controlling agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Water	(E00035)	962	Solvent